Organization
Novo Nordisk Canada Inc.
- Meetings this Parliament
- 41
- With MPs
- 20
- Since Nov 2021
- 102
- Active registrations
- 1
Most recent reported meeting: Sep 25, 2026.
Lobbying by Novo Nordisk Canada Inc.: its registrations, its lobbyists, the bills it has named and every meeting it has reported with federal office holders since November 2021.
← LobbyingRegistrations in effect
In-house (organization) In effect since Sep 18, 2026
Filed by Iain Graham, General Manager
Lobbyists
-
Gabrielle Berard · Director, External Affairs
Former designated public office holder
Formerly Director of Parliamentary Affairs, Senate of Canada, Parliament of Canada (2017–2018)
Formerly Policy Advisor, Office of the Minister of Finance, Finance Canada (2011–2014)
- Luka Stevanovic · External Affairs Associate Director
- Michael Tucker · Patient Access Manager, Atlantic
Institutions they may lobby: Agriculture and Agri-Food Canada (AAFC), Canada Foundation for Innovation, Canadian Heritage (PCH), Canadian Human Rights Tribunal (CHRT), Canadian Institutes of Health Research (CIHR), Employment and Social Development Canada (ESDC), Finance Canada (FIN), Global Affairs Canada (GAC), Health Canada (HC), House of Commons, Indigenous Services Canada (ISC), Innovation, Science and Economic Development Canada (ISED), Intergovernmental Affairs Secretariat (IGA), National Research Council (NRC), Parks Canada (PC), Patented Medicine Prices Review Board (PMPRB), Prime Minister's Office (PMO), Privy Council Office (PCO), Public Health Agency of Canada (PHAC), Senate of Canada, Treasury Board Of Canada Secretariat (TBS)
What they're lobbying on (9)Hide details
- Policy measures to ensure security of drug supply in Canada and preserve Canada's attractiveness for biopharmaceutical launches, including in response to foreign pricing regulations.
- Advocating in support of Bill S-201, An Act respecting a national framework on sickle cell disease.
- Free trade agreements as they relate to the biopharmaceutical industry.
- Biomanufacturing and Life Sciences Strategy (BLSS) as it relates to the biopharmaceutical industry.
- Policies and frameworks to accelerate access to innovative medicines post-Health Canada approval, including efforts to reduce time-to-reimbursement and streamline federal/provincial listing processes.
- Bill C-64, the Pharmacare Act, with respect to definitional questions related to terms contained in Section 6.1, and concerns regarding the increased risk of drug shortages.
- Communication around existing drug shortages and shared solutions to mitigate the impact on Canadians.
- Advocate for the implementation of a federal diabetes and obesity strategy.
- Advocate for the establishment of public-private partnerships to support chronic disease prevention.
Registration 963537-360616-26. Look it up in the official Registry
Reported meetings
SpreadsheetFiled by Vince Lamanna (55), Béatrice Clerc (26), Iain Graham (21).
-
Reported by Vince Lamanna · In-house (organization)
- Rechie Valdez · Minister of Small Business, Innovation, Science and Economic Development Canada (ISED)
- Chris Zhou · Director of Policy (Acting), Innovation, Science and Economic Development Canada (ISED)
- Christiana Osei · Digital Media and Communications Advisor, Innovation, Science and Economic Development Canada (ISED)
- Ajay Rakhra · Senior Advisor, Ontario and Stakeholder Relations, Innovation, Science and Economic Development Canada (ISED)
Health
-
Reported by Vince Lamanna · In-house (organization)
- Adam Chambers · Member of Parliament
Health
-
Reported by Vince Lamanna · In-house (organization)
- Eshan Naik · Director of Policy, Health Canada (HC)
Health
-
Reported by Vince Lamanna · In-house (organization)
- Matthew Trnkus · Policy Advisor, Global Affairs Canada (GAC)
HealthInternational Trade
-
Reported by Vince Lamanna · In-house (organization)
- Andrew Cardozo · Senator, Senate of Canada
Health
-
Reported by Vince Lamanna · In-house (organization)
- Chelios Vuong · Policy Advisor, Global Affairs Canada (GAC)
HealthInternational Trade
-
Reported by Vince Lamanna · In-house (organization)
- Jeremy Bruce · Deputy Director, Policy, Global Affairs Canada (GAC)
HealthInternational Trade
-
Reported by Vince Lamanna · In-house (organization)
- Judith Seidman · Senator, Senate of Canada
Health
-
Reported by Vince Lamanna · In-house (organization)
- Tom Kmiec · Member of Parliament
- Blaine Calkins · Member of Parliament
- Stephen Ellis · Member of Parliament, Cumberland-Colchester, House of Commons
- Earl Dreeshen · Member of Parliament, House of Commons
HealthResearch and DevelopmentScience and Technology
-
Reported by Vince Lamanna · In-house (organization)
- Sharon Burey · Senator, Senate of Canada
Health
-
Reported by Vince Lamanna · In-house (organization)
- Randy Hoback · Member of Parliament
HealthInternational Trade
-
Reported by Vince Lamanna · In-house (organization)
- Jade Mallette · Director of Parliamentary Affairs, Health Canada (HC)
Health
-
Reported by Vince Lamanna · In-house (organization)
- Shuvaloy Majumdar · Member of Parliament
Health
-
Reported by Vince Lamanna · In-house (organization)
- Eshan Naik · Director of Policy, Health Canada (HC)
Health
-
Reported by Vince Lamanna · In-house (organization)
- Connor MacDonald · Policy Advisor, House of Commons
- Jwane Izzetpanah · Manager of Stakeholder Relations, House of Commons
Health
-
Reported by Vince Lamanna · In-house (organization)
- Ritu Banerjee · Assistant Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
- Rodrigo Arancibia · Director, Innovation, Science and Economic Development Canada (ISED)
HealthResearch and Development
-
Reported by Vince Lamanna · In-house (organization)
- Nancy Hamzawi · Executive Vice President, Public Health Agency of Canada (PHAC)
- Stephen Lucas · Deputy Minister, Health Canada (HC)
- Michael Collins · Vice-President, Public Health Agency of Canada (PHAC)
- Celia Lourenco · Acting Associate Assistant Deputy Minister, Health Canada (HC)
and 1 moreShow fewer
- Marie-Pier Fontaine · Senior Policy Advisor, Health Canada (HC)
Health
-
Reported by Vince Lamanna · In-house (organization)
- Rechie Valdez · Minister of Small Business, Innovation, Science and Economic Development Canada (ISED)
- Chris Zhou · Senior Policy and Atlantic Advisor, Innovation, Science and Economic Development Canada (ISED)
Health
-
Reported by Vince Lamanna · In-house (organization)
- Jennifer Miller · Assistant Secretary, Privy Council Office (PCO)
- Jeff Waring · Associate Assistant Secretary, Privy Council Office (PCO)
Health
-
Reported by Vince Lamanna · In-house (organization)
- Eshan Naik · Director of Policy, Health Canada (HC)
Health
-
Reported by Vince Lamanna · In-house (organization)
- Luc Thériault · Member of Parliament
Health
-
Reported by Vince Lamanna · In-house (organization)
- Josh Dadjo · Director of Parliamentary Affairs, Senate of Canada
Health
-
Reported by Vince Lamanna · In-house (organization)
- Ben Chin · Senior Advisor, Prime Minister's Office (PMO)
Health
-
Reported by Vince Lamanna · In-house (organization)
- Suzy McDonald · Associate Deputy Minister, Finance Canada (FIN)
Health
-
Reported by Vince Lamanna · In-house (organization)
- Eshan Naik · Director of Policy, Health Canada (HC)
- Chelsea Madryga · Policy Advisor, Health Canada (HC)
Health
From the Office of the Commissioner of Lobbying's open data, published November 5, 2026. Reports cover oral, arranged meetings with designated public office holders since November 22, 2021; lobbyists file them by the 15th of the following month. Names of MPs are matched to the current House of Commons, and bills are linked when the lobbyist's own description makes clear which bill it means. Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying. Licence. PolitiKit is independent and is not endorsed by the Commissioner of Lobbying.